Model System Caenorhabditis Elegans in Drug Research: an Overview 1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
ANNUAL REVIEW 1 October 2005–30 September
WELLCOME TRUST ANNUAL REVIEW 1 October 2005–30 September 2006 ANNUAL REVIEW 2006 The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. www.wellcome.ac.uk THE WELLCOME TRUST The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. 123 CONTENTS BOARD OF GOVERNORS 2 Director’s statement William Castell 4 Advancing knowledge Chairman 16 Using knowledge Martin Bobrow Deputy Chairman 24 Engaging society Adrian Bird 30 Developing people Leszek Borysiewicz 36 Facilitating research Patricia Hodgson 40 Developing our organisation Richard Hynes 41 Wellcome Trust 2005/06 Ronald Plasterk 42 Financial summary 2005/06 Alastair Ross Goobey 44 Funding developments 2005/06 Peter Smith 46 Streams funding 2005/06 Jean Thomas 48 Technology Transfer Edward Walker-Arnott 49 Wellcome Trust Genome Campus As at January 2007 50 Public Engagement 51 Library and information resources 52 Advisory committees Images 1 Surface of the gut. 3 Zebrafish. 5 Cells in a developing This Annual Review covers the 2 Young children in 4 A scene from Y fruit fly. Wellcome Trust’s financial year, from Kenya. Touring’s Every Breath. 6 Data management at the Sanger Institute. 1 October 2005 to 30 September 2006. CONTENTS 1 45 6 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health. -
Vol 9 No 1 Spring
A PUBLICATION OF THE AMERICAN SOCIETY FOR MATRIX BIOLOGY SPRING 2010, VOLUME 9, NO. 1 President’s Letter Expanding the Society’s Value to You and Your Role in the Society Since its inception in 2001, the principal function of the ASMB has been to organize the OFFICERS biennial meeting. The value of this meeting to our members cannot be understated. The ASMB meeting has emerged as the matrix-centric President: meeting in North America, and it provides an William Parks (2010) open venue for students, postdocs, fellows, and junior faculty to present their work and to inter- act with established investigators. Speaking for Vice Pres/President Elect myself, I very much look forward to the ASMB Jean Schwarzbauer (2010) meeting, not only because I get to see many Bill Parks friends, but also to hear a lot of incredibly good science. This year’s meeting will be no excep- Past President: tion and promises to be truly outstanding. I applaud Jean Schwarzbauer and the Renato Iozzo (2010) rest of the Program Committee for putting together an exciting meeting loaded with interesting topics and great speakers (please check out the program here). By organizing the meeting, ASMB provides value to you, the membership, but I Secretary/Treasurer think we–the Society–should always be looking to do more; that is, to provide more Joanne Murphy-Ullrich (2011) bang for your dues buck. For this year’s meeting, we have expanded the Travel Awards that will be given to trainees in recognition of outstanding research, and we recently established merit-based Minority Scholarships that will be awarded to eli- Council Members gible students and postdocs. -
SAC 2014 Celebration of Science Book
Fostering Innovation at MGH Poster Session Abstracts 67th Annual Meeting of the MGH Scientific Advisory Committee Celebration of Science The MGH Research Institute: Meeting the Challenges that Lie Ahead April 2 & 3, 2014 Simches Auditorium 185 Cambridge Street, 3rd Floor Management Management ECOR Administrative Offices | 50 Staniford Street, 10th Floor | Boston, MA 02114 | [email protected] Fostering Mainstay Mainstay Innovation of MGH of MGH at MGH Management Innovation Management Innovation Welcome elcome to the 67th Annual Meeting of the MGH Scientific Advisory Committee (SAC) on April 2nd and 3rd, 2014. Dr. Richard Lifton has graciously agreed to W chair our SAC meeting again this year. As in past years, we will begin our two-day SAC meeting with a Celebration of Science at MGH. Our poster session begins at 11:00 am on Wednesday, April 2, followed by an afternoon Research Symposium from 2:00 pm to 5:00 pm. The outstanding MGH researchers who will be presenting their work in our Symposium this year are the 2014 Howard Goodman Award recipient Filip Swirski, PhD and the 2014 Martin Basic and Clinical Research Prize recipients, Jayaraj Rajagopal, MD, and Stephanie Seminara, MD. We are honored to have as our keynote speaker, Richard O. Hynes, PhD, from MIT. We will close the first day with a Reception for invited guests at the Russell Museum. On Thursday, April 3, Dr. Kingston will open the SAC meeting with an ECOR Report. After this report, Anne Klibanski, MD, Partners Chief Academic Officer, will give a presentation on the Integration of MGH Research to the Partners Enterprise. -
List of Life Members As on 20Th January 2021
LIST OF LIFE MEMBERS AS ON 20TH JANUARY 2021 10. Dr. SAURABH CHANDRA SAXENA(2154) ALIGARH S/O NAGESH CHANDRA SAXENA POST HARDNAGANJ 1. Dr. SAAD TAYYAB DIST ALIGARH 202 125 UP INTERDISCIPLINARY BIOTECHNOLOGY [email protected] UNIT, ALIGARH MUSLIM UNIVERSITY ALIGARH 202 002 11. Dr. SHAGUFTA MOIN (1261) [email protected] DEPT. OF BIOCHEMISTRY J. N. MEDICAL COLLEGE 2. Dr. HAMMAD AHMAD SHADAB G. G.(1454) ALIGARH MUSLIM UNIVERSITY 31 SECTOR OF GENETICS ALIGARH 202 002 DEPT. OF ZOOLOGY ALIGARH MUSLIM UNIVERSITY 12. SHAIK NISAR ALI (3769) ALIGARH 202 002 DEPT. OF BIOCHEMISTRY FACULTY OF LIFE SCIENCE 3. Dr. INDU SAXENA (1838) ALIGARH MUSLIM UNIVERSITY, ALIGARH 202 002 HIG 30, ADA COLONY [email protected] AVANTEKA PHASE I RAMGHAT ROAD, ALIGARH 202 001 13. DR. MAHAMMAD REHAN AJMAL KHAN (4157) 4/570, Z-5, NOOR MANZIL COMPOUND 4. Dr. (MRS) KHUSHTAR ANWAR SALMAN(3332) DIDHPUR, CIVIL LINES DEPT. OF BIOCHEMISTRY ALIGARH UP 202 002 JAWAHARLAL NEHRU MEDICAL COLLEGE [email protected] ALIGARH MUSLIM UNIVERSITY ALIGARH 202 002 14. DR. HINA YOUNUS (4281) [email protected] INTERDISCIPLINARY BIOTECHNOLOGY UNIT ALIGARH MUSLIM UNIVERSITY 5. Dr. MOHAMMAD TABISH (2226) ALIGARH U.P. 202 002 DEPT. OF BIOCHEMISTRY [email protected] FACULTY OF LIFE SCIENCES ALIGARH MUSLIM UNIVERSITY 15. DR. IMTIYAZ YOUSUF (4355) ALIGARH 202 002 DEPT OF CHEMISTRY, [email protected] ALIGARH MUSLIM UNIVERSITY, ALIGARH, UP 202002 6. Dr. MOHAMMAD AFZAL (1101) [email protected] DEPT. OF ZOOLOGY [email protected] ALIGARH MUSLIM UNIVERSITY ALIGARH 202 002 ALLAHABAD 7. Dr. RIAZ AHMAD(1754) SECTION OF GENETICS 16. -
Department of Biotechnology Annual Report
DEPARTMENT OF BIOTECHNOLOGY INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI ANNUAL REPORT APRIL 2011 to MARCH 2012 Page 1 of 38 1. INTRODUCTION Contributing to the fascinating and emerging areas of Science, Indian Institute of Technology Guwahati established Department of Biotechnology in the year 2002. The Department is one of its kind in the north-eastern region of Indian and is dedicated for promoting goal-oriented interdisciplinary research by interfacing modern biology with applied engineering sciences, addressing problems affecting human health/welfare, and training students to be the next generation engineers and researchers. As of now, the department has twenty-five faculty members from diverse streams and specializations, eight well-trained scientific staff members, and two administrative staff members. The detailed activities of the Department of the Biotechnology are given in below. 2. ACADEMIC ACTIVITIES: The department offers B. Tech., M. Tech., and PhD programmes. 3. STUDENT INTAKE: 46 in B. Tech., 30 in M. Tech, and 31 in Ph. D. 4. FACULTY STRENGTH: 25 (as on March 31, 2012). 5. MAJOR EQUIPMENTS AND FACILITIES Atomic Force Microscope - Contact Mode, Autotensiometer, Bioreactor, Trinocular Phase Contrast Microscope with Fluorescence attachment, Trinocular Stereo Zoom Microscope with Fibre Optic Light, DuoFlow, FACS Calibur Flowcytometer Analyser, Compact Spectrofluorometer, FPLC System, Digital Imaging System, Gradient PCR Thermal Cycler, HPLC System, Ion Chromatography system, Gas Chromatography system, Bioreactors, Freeze Dryer, Manual Rotary Microtome, Multimode Microplate Reader, Real-Time PCR System, Ultracentrifuge 6. RESEARCH AND DEVELOPMENT ACTIVITIES The research in the Department of Biotechnology covers as diverse areas as biochemical engineering, plant biotechnology, environmental biotechnology, nanobiotechnology, protein and peptide chemistry, molecular biology, structural and computational biology, bioinformatics, parasite biology, tissue engineering, stem cell biology and gene therapy, enzymology, and proteomics. -
Hhmi Bulletin 3 4 Hhmi Club
HHMI BULLETIN 4000 Jones Bridge Road • Chevy Chase, Maryland 20815-6789 Howard Hughes Medical Institute www.hhmi.org One Lump or Two? in this issue Once again, those fast-growing yeast find a way to turn a The Silicon Marvel long-held theory on its head. This time, it’s about prions, • Prions for Good which aren’t as universally nasty as once suspected. Some may actually help organisms evolve. The yeast colony shown here www.hhmi.org A Kaleidoscopic View contains a protein in its prion form. Because the prion, known as PSI+, is self-replicating and forms fibrous amyloids, the yeast look lumpy and bumpy—strikingly different from normally smooth yeast. Susan Lindquist’s group has found 19 yeast proteins that can switch back and forth between a normal and a prion version. The prions are thought to help the yeast adapt to changing conditions (see “A Silver Lining,” page 22). LIGHT MOVES v ol. 23 Heather True / Lindquist lab /no. 02 O b s e r v a t i O n s 16 Secret Agent MAn Skin cells do more than just cover our bodies. As a neurology resident, Stanley Prusiner saw Creutzfeldt–Jakob agent began to emerge. These data established, for the first time, that Keratinocytes, for example, anchor immune cells disease kill a patient in a matter of months. Researchers knew the rare a particular macromolecule was required for infectivity and that this within the epidermis, move and proliferate during neurodegenerative disease and scrapie, a similar disease in sheep, macromolecule was a protein …. wound healing, and even secrete inhibitory molecules were infectious but not as a result of a typical virus. -
Summarised Financial Statements 2012
Summarised Financial Statements 2012 Contents Chairman’s Statement 02 02 Summary Trustee’s Report 04 04 Vision and Objects, Mission, Focus Areas 04 and Challenges Financial Review 06 Extracts from the Review of Investment Activities 08 Independent Auditors’ Report 10 10 Consolidated Statement of Financial Activities 11 Consolidated Balance Sheet 12 Consolidated Cash Flow Statement 13 Grants Awarded 14 Reference and Administrative Details 16 Chairman’s Statement Sustained investment in research can bring real benefits or Medicine which was shared by a dozens of genomes every day. Their former Governor of the Trust, work is driving the first wave of Professor Sir John Gurdon. His work stratified medicine, improving cancer showed that mature cells had the therapy for patients by examining the potential to be reprogrammed into genetics of individual tumours, and stem cells. Subsequent decades of revealing the genetic basis of the way investment in stem cell research have specific cancers respond to different brought us ever closer to realising the drugs. promise of stem cell therapies. At the same time, ever-improving We saw again this year how sustained technology is giving us an advantage investment in research can bring real against infectious diseases. A study benefits. Genetics has been one of the published this summer demonstrated Trust’s most focused areas of funding how modern genome sequencing Summary of Chairman’s since the mid-1990s. First, we sought could track methicillin-resistant Statement to decode the human genome; then Staphylococcus aureus (MRSA). we had to find ways to apply that Retrospective analysis of samples • We committed £701 million in grant knowledge. -
February 7, 2007 (Download PDF)
Volume 51 – Number 16 Wednesday – February 7, 2007 TechTalk S ERVING T HE M I T C OMMUNITY Reactivated gene shrinks tumors, MIT study finds Anne Trafton cancer treatments,” said David Kirsch of known whether such activity would actu- properly, it activates DNA repair mecha- News Office MIT’s Center for Cancer Research and ally reverse tumor growth in primary nisms and prevents cells with damaged Harvard Medical School, one of the lead tumors. DNA from dividing. If DNA damage is co-authors of the paper. The new MIT study shows that re-acti- irreparable, p53 induces the cell to destroy Many cancers arise due to defects in The study appeared in the Jan. 25 vating p53 in mouse tumors dramatically itself by undergoing apoptosis, or pro- genes that normally suppress tumor issue of Nature. It was conducted in the reduces the size of the tumors, in some grammed cell death. growth. Now, for the first time, MIT laboratory of Tyler Jacks, director of the cases by 100 percent. When p53 is turned off by mutation researchers have shown that re-activat- Center for Cancer Research, the David H. “This study provides critical genetic or deletion, cells are much more likely ing one of those genes in mice can cause Koch Professor of Biology and a Howard evidence that continuous repression of a to become cancerous, because they will tumors to shrink or disappear. Hughes Medical Institute investigator. tumor suppressor gene is required for a divide uncontrollably even when DNA is The study offers evidence that the P53 has long been known to play a tumor to survive,” said Andrea Ventura, an damaged. -
Advances in Biological Science 2014
DEPARTMENT OF BIOTECHNOLOGY, OBJECTIVES AND FEATURES CONVENER: Dr Bhupendra Pushkar Science has become an indispensable UNIVERSITY OF MUMBAI Dept.Of Biotechnology, Univ of Mumbai part of human life. The contribution of scientific innovations and developments has led to the utter SCHEDULED PROGRAM transformation of lifestyle of human beings in today’s world. One of the most promising area of INAUGRAL SESSION technological advancements is the domain of biosciences. The research in biosciences has touched Prof. Dr.G.D.Yadav, Vice Chancellor, ICT Mumbai human lives in every possible niches although we do Prof.Dr.S.P.Modak, Founder &Coordinator of not realise it in our daily activities. The ORGANIZES Biotechnology Training Programme multidisciplinary nature of biosciences has rendered University Of Pune One Day significant contributions in fermentation industry, Dr.Bhupendra Pushkar, Head, Dept.Of medicine, agriculture or environment industry. The Biotechnology, Univ of Mumbai NATIONAL CONFERENCE underlying idea behind holding this conference is to bring together leading academic scientists, SESSION I ON researchers, students from different institutes, Prof. R. V. Hosur, Director, CBS, Mumbai laboratories & colleges in one forum to exchange Dr. Dulal Panda, Professor Biotechnology, and share their experiences about various aspects of IIT-Mumbai ADVANCES IN BIOLOGICAL bioscience. Keeping in mind these facts, objectives of Dr.Vinay Kumar, Scientist, BARC this conference are: SCIENCE SESSION II To explore and discuss the importance various December 23, 2014 Dr. Pradeep K Verma, Scientist & Head disciplines of biosciences. Marine Biotechnology, NMRL Dr.Vikrant M Bhor, Scientist, NIRRH Venue: Pherozshah Mehta To give a brief overview of recent trends and Dr. Madhuri Sheron, Executive & Research future prospects of research in Biological Science Director, N. -
ANNUAL REPORT April 2009 to March 2010
Ôããè ¡ãè †¹ãŠ ¡ãè CDFD ÌãããäÓãÇ㊠¹ãÆãä¦ãÌãñª¶ã ‚ã¹ãÆõÊã 2009 Ôãñ ½ããÞãà 2010 ¦ã‡ãŠ ANNUAL REPORT April 2009 to March 2010 ¡ãè †¶ã † ãä¹ãâŠØãÀãä¹ãÆâãä›âØã †Ìãâ ãä¶ãªã¶ã ‡ãñж³ ¶ãã½ã¹ãÊÊããè, ÖõªÀãºã㪠- 500 001 Centre for DNA Fingerprinting and Diagnostics Nampally, Hyderabad - 500 001 1 2 CONTENTS I Mandate 5 II From the Director’s Desk 9 III Services 1. Laboratory of DNA Fingerprinting Services 15 2. Diagnostic Services 18 IV Research 1. Laboratory of Molecular Genetics 27 2. Laboratory of Genomics and Profiling Applications 35 3. Laboratory of Fungal Pathogenesis 40 4. Laboratory of Immunology 44 5. Laboratory of Bacterial Genetics 48 6. Laboratory of Computational Biology 53 7. Laboratory of Molecular Cell Biology 57 8. Laboratory of Structural Biology 61 9. Laboratory of Mammalian Genetics 65 10. Laboratory of Molecular Oncology 69 11. Laboratory of Cancer Biology 74 12. Laboratory of Computational and Functional Genomics 78 13. Laboratory of Transcription 83 14. Laboratory of Cell Signalling 87 15. Laboratory of Plant Microbe Interaction 91 16. Other Scientific Services / Facilities a. Bioinformatics 97 b. Instrumentation 98 V Publications 99 VI Human Resource Development 107 VII Lectures, Meetings, Workshops, and Important Events 111 VIII Senior Staff and Officers of CDFD 115 IX Deputations Abroad of CDFD Personnel 119 X Committees of the Institute 123 XI Budget and Finance 133 XII Auditor’s Report 137 XIII Photo Gallery 227 3 4 Mandate 5 6 MANDATE The objectives for which the Centre for DNA Fingerprinting and Diagnostics (CDFD) was established as enumerated in Memorandum of Association and Rules and Regulations of CDFD Society are as follows: i. -
DBT-CDFD Researchers Decode How TB Causing Bacteria Evades Immunity
DBT-CDFD researchers decode how TB causing bacteria evades immunity New Delhi, June 23: Mycobacterium tuberculosis (M. tuberculosis), which causes tuberculosis (TB) disease, has evolved several adaptive skills and evasion mechanisms to escape the defence system of the body and continue to survive within what are called macrophages. Normally, macrophages engulf invading bacteria and kill and digest them with the help of an inter-cellular organelle called lysosome. The process involves the production of reactive oxygen species (ROS) or reactive nitrogen species (NO). This creates an oxidative stress, which then leads to the destruction of the bacteria. In the case of Mycobacterium tuberculosis, however, this does not happen. It has evolved strategies to avoid oxidative stress caused by NO/ROS. A team of researchers at the Department of Biotechnology’s Centre for DNA Fingerprinting And Diagnostics (DBT-CDFD), Hyderabad have now got an insight into the nefarious strategy. They have identified a protein that seems to limit the oxidative stress mediated by reactive oxygen species (ROS) or reactive nitrogen species (NO). It belonged to a family of secretory protein of M. tuberculosis called PPE. The protein named PPE2has a monopartite nuclear localization signal (NLS), a DNA binding domain and an eukaryotic SH3 domain. PPE2 is translocated into the macrophage nucleus via the classical importin α/β pathway to interact with a GATA-binding site overlapping with the TATA box of inos promoter and inhibit NO production. PPE2 enhances the survival of the bacilli in macrophages as well as in a mice infection model. In addition to having NLS and DNA binding domain, bioinformatics study revealed the presence of eukaryotic like SH3 domain and a PxxP motif in PPE2. -
Awardees of National Bioscience Award for Career Development
AWARDEES OF NATIONAL BIOSCIENCE AWARD FOR CAREER DEVELOPMENT Awardees for the year 2016 1. Dr. Mukesh Jain, Associate Professor, School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi-110067 2. Dr. Samir K. Maji, Associate Professor, Indian Institute of Technology, Powai, Mumbai- 400076 3. Dr. Anindita Ukil, Assistant Professor, Calcutta University, Kolkata 4. Dr. Arnab Mukhopadhyay, Staff Scientist V, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi- 110067 5. Dr. Rohit Srivastava, Professor, Indian Institute of Technology, Bombay, Mumbai- 400076 6. Dr. Pinaki Talukdar, Associate Professor, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pashan, Pune- 7. Dr. Rajnish Kumar Chaturvedi, Senior Scientist, CSIR- Indian Institute of Toxicology Research, Lucknow-226001 8. Dr. Jackson James, Scientist E-II, Neuro Stem Cell Biology Lab, Neurobiology Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala- 695014 Awardees for the year 2015 1. Dr. Sanjeev Das, Staff Scientist-V, National Institute of Immunology, New Delhi 2. Dr. Ganesh Nagaraju, Assistant Professor, Department of Biotechnology, Indian Institute of Science, Bangalore- 5600012. 3. Dr. Suvendra Nath Bhattacharya, Principal Scientist, CSIR- Indian Institute of Chemical Biology, Kolkata- 700032 4. Dr. Thulasiram H V, Principal Scientist, CSIR-National Chemical Laboratory, Pune- 411008. 5. Dr. Pawan Gupta, Principal Scientist, Institute of microbial Technology, Chandigarh- 160036. 6. Dr. Souvik Maiti, Principal Scientist, CSIR-Institute of Genomics and Integrative Biology, Delhi- 110025. 7. Dr. Pravindra Kumar, Associate Professor, Department of Biotechnology, IIT, Roorkee- 247667. 8. Dr. Anurag Agrawal, Principal Scientist, CSIR-Institute of Genomics and Integrative Biology, Delhi- 110025 9. Dr. Gridhar Kumar Pandey, Professor, Department of Plant Molecular Biology, University of Delhi South Campus, New Delhi- 110067 10.